As shown in Figure 8E, SpaBatch indeed identified that the cancer in situ region recovered from domain 3 highly expresses the breast cancer marker ERBB2 compared to other regions.[22] Next, we investigated the heterogeneity of the cancer regions. This evidence concerns the gene ERBB2 and breast carcinoma.